Tolvaptan Extension Study in Participants With ADPKD

Clinical trial NCT01214421 · COMPLETED

Trial details

NCT number: NCT01214421
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Start date: 2010-05-26
Primary completion: 2016-02-29
Enrollment: 1083

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.